Representative Rosa L. DeLauro introduces H.R. 10924: Medicare for America Act of 2026

We have received text from H.R. 10924: Medicare for America Act of 2026. This bill was received on 2026-10-29, and currently has no cosponsors.

Here is a short summary of the bill:

This bill would replace much of the current U.S. health coverage system with a new national program called Medicare for America . Most residents would be automatically enrolled in the program. The law would provide broad health benefits, including hospital care, doctor visits, prescription drugs, and other services. Premiums would generally be based on income, with lower-income people paying little or nothing. The bill also removes deductibles and limits how much people would have to pay out of pocket.

Coverage and benefits

The new program would cover a wide range of medical services and would set standard payment rates for providers. It would also prohibit several common forms of cost-sharing and billing practices, including:

• deductibles
• balance billing beyond set limits
• lifetime coverage limits
• certain private insurance contracts that duplicate the public benefit
• step therapy and prior authorization in many cases

The bill also expands protections against discrimination in health care. It preserves other civil rights laws already in place, but also says providers cannot refuse services based on religious objections.

Prescription drugs and pricing

The bill would create a stronger federal role in controlling drug prices. The government would negotiate prices for prescription drugs, and if negotiations failed, the law could allow licensing or other measures to lower costs. It would also create a federal board to monitor drug and device pricing, identify excessive prices, and impose penalties or taxes in some cases. Drug companies would have to report price increases, and direct-to-consumer advertising for newly approved drugs would be barred for three years after approval.

Changes to existing health programs

Over time, the bill would phase out several existing public coverage systems as the new program takes over. This would include:

• Medicare
• Medicaid
• CHIP
• state health insurance exchanges

These changes would happen gradually and are described as taking effect by roughly 2033 to 2035. At the same time, some systems would continue unchanged, including:

• the Federal Employees Health Benefits Program (FEHBP)
• TRICARE
• veterans’ health benefits
• Indian Health Service benefits

Employer and state responsibilities

The bill would establish rules for employers, including required contributions toward health coverage. It would also require states to make certain maintenance-of-effort payments to remain eligible for funding. States that do not meet those requirements could lose funding support under the bill.

Access to care and provider rules

The bill includes rules aimed at improving access to care and limiting barriers to treatment. It would require Medicare Advantage plans to meet network adequacy standards and would create enforcement tools if they do not. It would also end the 24-month waiting period for people who qualify for Medicare because of disability. In addition, it would enroll some people who are on Medicaid waiting lists.

For hospitals and nursing homes, the bill would require staffing ratios and greater transparency. It also creates specific compliance deadlines, including delayed implementation for licensed practical nurse staffing rules. Facilities that fail to comply could face penalties or other enforcement action. Whistleblower protections and complaint procedures would be strengthened so workers and others can report violations.

Administration, appeals, and enforcement

The bill creates new administrative rules for the program, including appeals procedures. It also establishes a dedicated trust fund to help finance the system and support its operations. The federal government would have expanded authority to enforce compliance with coverage, pricing, and provider rules through reporting requirements, penalties, and oversight.

Relevant Companies

• UNH — UnitedHealth Group could be affected by changes to Medicare Advantage, private insurance coverage, and reimbursement rules.
• HUM — Humana could be affected by new Medicare Advantage network standards and broader changes to public coverage programs.
• CVS — CVS Health could be affected through its health insurance, pharmacy benefit, and Medicare-related businesses.
• CNC — Centene could be affected by the phaseout of Medicaid and state exchange coverage and by changes to managed care reimbursement.
• MRK — Merck could be affected by federal drug price negotiation and pricing controls.
• PFE — Pfizer could be affected by drug pricing rules, price-increase reporting, and limits on direct-to-consumer advertising for new drugs.
• BMY — Bristol Myers Squibb could be affected by prescription drug price negotiation and pricing enforcement measures.
• LLY — Eli Lilly could be affected by federal drug pricing controls and reporting requirements.
• ABBV — AbbVie could be affected by negotiated drug pricing and related federal cost-control measures.

Representative Rosa L. DeLauro Bill Proposals

Here are some bills which have recently been proposed by Representative Rosa L. DeLauro:

• H.R.10924: Medicare for America Act of 2026
• H.R.10544: Ovarian Cancer IMPACT Act
• H.R.9458: Wage Theft Prevention and Wage Recovery Act
• H.R.9347: CHILD Labor Act
• H.R.9015: Physician Education for Fistula Treatment Act
• H.R.8964: DONOR Milk Act

You can track bills proposed by Representative Rosa L. DeLauro on Investivoq's politician page for DeLauro.

Representative Rosa L. DeLauro Net Worth

Investivoq estimates that Representative Rosa L. DeLauro is worth $3.2M, as of November 9th, 2026. This is the 225th highest net worth in Congress, per our live estimates.

DeLauro has approximately $0 invested in publicly traded assets which Investivoq is able to track live.

You can track Representative Rosa L. DeLauro's net worth on Investivoq's politician page for DeLauro.

2026 Connecticut's 3rd Congressional District Election

There has been approximately $1,804,158 of spending in Connecticut's 3rd congressional district elections over the last two years, per our estimates.

The rating for this race is currently "Solid D".

You can track this election on our matchup page for the 2026 Connecticut's 3rd congressional district election.

This article is not financial advice. See Investivoq's disclaimers for more information.